The legacy of the blue pill offers a intricate case study for stakeholders eyeing pharma. While initial sales were remarkable, current patent lapse and the arrival of generic versions have significantly affected earnings. Moreover, growing regulatory scrutiny and calls to reduce prescription prices pose ongoing challenges. Therefore, betting on … Read More

The emergence of so-called "Premium Gambler's Viagra" – often referring to exceptionally high doses administered by unscrupulous physicians – represents a particularly alarming trend. While typical dosages of Viagra are intended for treating erectile dysfunction safely in most men, these significantly elevated quantities pose a significant thre… Read More